Login
Cardinal Health NYSE: CAH
Cardinal Health has a wide range of professional medical products from anesthesia-related equipment to laboratory products down to consumables such as gloves
| Name | Cardinal Health |
| Ticker | CAH |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Consumables & Intermediates |
| Price | 53.78 |
| 52W Low/High | 41.00 / 60.42 |
| Market cap | 16 B |
| 1Y Total Return |
0.89%
Average |
| 1Y Volatility |
45.56%
Less Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Cardinal Health has a wide range of professional medical products from anesthesia-related equipment to laboratory products down to consumables such as gloves
Details
| Ticker | CAH |
| Name | Cardinal Health |
| ISIN | US14149Y1082 |
| CUSIP | 14149Y108 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Medical Consumables & Intermediates |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) | US S&P 500 Index |
Share as of 11/27/20
| Close Price | 53.78 |
| 52W Low/High | 41.00 / 60.42 |
| Market cap | 16 B |
| 1Y Total Return |
0.89%
Average |
| 1Y Volatility |
45.56%
Less Risk |
| Beta | 1.82 |
| PE (trailing) |
16.25
Below Average |
| 12M Dividends | 1.934 |
| Last Dividend Date | 9/30/20 |
| Dividend Yield | 3.60% |
Fin. Strength
| Net Profit Margin | 0.6% |
| Cash from Op. / Cur. Liabilities | 0.12 |
| Diluted Earnings / Share | 3.31 |
| ROE | 83.8% |
| ROIC | 7.3% |
| Price / Revenue | 0.1 |
| Price / Book | 11.1 |
| Price / CF | 5.5 |
| Current Ratio | 1.1 |
| Cur.Liabilities / Tot.Liabilities | 0.6 |
| Financial Leverage | 4.74 |
| in Mils USD |
rolling-year up to September
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
154,646
|
147,662
|
139,381
|
130,578
|
125,530
|
106,515
|
|
| Gross Profit |
6,904
|
6,847
|
7,176
|
6,625
|
6,554
|
5,950
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
2,008
|
-3,058
|
1,703
|
2,612
|
3,052
|
2,733
|
|
| Operating Income |
564
|
-4,044
|
656
|
1,847
|
2,379
|
2,311
|
|
| Net Income exc. Extra |
973
|
-
|
735
|
1,094
|
1,353
|
1,332
|
|
| per Share | |||||||
| Diluted avg Shares |
293
|
296
|
306
|
318
|
322
|
331
|
|
| EPS exc. Extra |
3.31
|
-14.08
|
2.39
|
3.44
|
4.13
|
3.98
|
|
| Dividend |
1.93
|
1.91
|
1.88
|
1.82
|
1.67
|
1.46
|
|
| Div. Yield (an.) |
4.12%
|
4.06%
|
3.48%
|
2.72%
|
2.15%
|
1.90%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
41,727
|
39,179
|
40,011
|
41,940
|
34,406
|
31,222
|
|
| Cash, Eq & Invt ShortTerm |
2,746
|
1,212
|
2,045
|
1,181
|
2,001
|
2,974
|
|
| Total Current Assets |
27,030
|
23,715
|
24,445
|
23,725
|
22,283
|
21,218
|
|
| Total Non-Current Assets |
14,697
|
15,464
|
15,566
|
18,215
|
12,123
|
10,004
|
|
| Intangibles |
11,186
|
11,658
|
12,093
|
14,926
|
9,427
|
7,564
|
|
| Total Liabilities |
40,302
|
38,276
|
34,098
|
35,245
|
27,875
|
24,695
|
|
| Total Current Liabilities |
24,016
|
22,549
|
23,057
|
22,407
|
20,001
|
17,782
|
|
| Long Term Debt |
16,286
|
15,727
|
11,041
|
12,838
|
7,874
|
6,913
|
|
| Shareholder equity |
1,422
|
900
|
5,913
|
6,678
|
6,512
|
6,505
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
2,883
|
1,704
|
1,952
|
2,261
|
3,127
|
2,427
|
|
| Depreciation |
884
|
989
|
1,048
|
773
|
677
|
480
|
|
| Cash from Investing |
472
|
-414
|
1,215
|
-6,439
|
-2,712
|
-2,246
|
|
| Capex |
381
|
342
|
375
|
354
|
482
|
294
|
|
| Cash from Financing |
-1,813
|
-2,114
|
-2,296
|
3,352
|
-1,377
|
324
|
|
| Stock Issued |
0
|
-350
|
-1,000
|
-500
|
-901
|
-701
|
|
| Debt (LT) Issued |
-1,365
|
-1,177
|
-594
|
4,432
|
12
|
1,431
|
|
| Free Cash Flow |
115
|
-5,362
|
1,220
|
3,182
|
2,936
|
830
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
0.6%
|
-
|
0.5%
|
0.8%
|
1.1%
|
1.3%
|
|
| NCFO / Op.Income |
511.2%
|
-
|
297.6%
|
122.4%
|
131.4%
|
105.0%
|
|
| Current Ratio |
1.1
|
1.1
|
1.1
|
1.1
|
1.1
|
1.2
|
|
| Financial Leverage D/E |
4.74
|
8.88
|
1.52
|
1.50
|
0.85
|
0.85
|
|
| Return on Capital Avg |
7.3%
|
-41.2%
|
4.9%
|
9.2%
|
12.4%
|
13.7%
|
|
| Return on Shareholder Equity |
83.8%
|
-
|
11.7%
|
16.6%
|
20.8%
|
20.9%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available